Testing effectiveness (Phase 2)WithdrawnNCT00005083
What this trial is testing
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center